Hub : Traits :

Allergy

1248 significantly associated models · 287 unique genes.

Significant Loci

# chr p0 p1 # assoc genes # joint genes best TWAS P best SNP P cond SNP P % var exp joint genes
1 1 2235672 2742491 2 1 1.1e-09 2.4e-10 1.0e-03 73 TNFRSF14
2 1 7686056 11137778 6 2 5.7e-14 1.9e-12 1.0e-01 94 KIF1B RERE
3 1 24372971 25768937 1 1 7.0e-10 2.2e-14 1.3e-08 44 CLIC4
4 1 26399230 26917014 2 1 8.3e-08 2.7e-07 1.0e+00 100 CD52
5 1 91271668 92681020 1 1 1.5e-07 4.4e-05 5.4e-01 98 CDC7
6 1 151313774 152712747 2 5 5.5e-21 4.3e-19 8.6e-01 100 LINGO4 S100A11
7 1 153024634 155138557 6 1 7.4e-13 8.6e-14 3.7e-04 77 IL6R
8 1 160452218 161885352 4 1 3.6e-09 1.7e-09 1.3e-01 94 PPOX
9 1 166702558 168182443 1 1 7.4e-20 1.3e-20 1.0e+00 100 CD247
10 1 172311679 173713130 2 1 1.4e-11 1.8e-11 1.0e+00 100 TNFSF4
11 2 27971195 29344127 1 1 7.8e-10 1.7e-07 1.8e-01 94 RP11-373D23.3
12 2 29976100 31563885 1 1 1.3e-07 1.9e-06 1.0e+00 100 LCLAT1
13 2 60466491 62107632 5 1 9.3e-10 1.1e-08 1.0e-07 13 KIAA1841
14 2 101994731 104027106 7 7 1.2e-84 2.4e-72 1.0e+00 100 IL18RAP IL1R1 IL1RL1 SLC9A2
15 2 197134790 200117777 6 1 2.3e-10 6.1e-11 7.8e-03 84 SF3B1
16 3 55969663 57412804 2 1 4.8e-08 3.6e-09 2.4e-02 85 FAM208A
17 4 38079294 39824758 5 2 3.5e-58 6.7e-60 4.4e-03 97 FAM114A1 TLR1
18 4 102852939 104627833 4 1 1.3e-09 6.4e-09 2.9e-01 97 NFKB1
19 4 122377715 124935698 3 4 8.0e-34 2.7e-30 1.0e+00 100 KIAA1109 SPATA5
20 5 34920257 36637217 4 2 5.9e-38 2.3e-40 1.0e+00 100 IL7R
21 5 108927715 111770880 6 9 2.0e-45 4.3e-60 NaN NaN CAMK4 SLC25A46 TMEM232 TSLP WDR36
22 5 130830617 132900729 15 7 3.2e-17 1.1e-18 NaN NaN C5orf56 KIF3A PDLIM4 SLC22A5
23 5 140298815 142230251 2 2 7.9e-12 3.8e-11 5.6e-01 99 AC008781.7 NDFIP1
24 5 176067604 177426530 2 1 3.6e-09 1.3e-08 2.3e-01 96 RGS14
25 6 25266147 26689223 2 1 5.5e-12 1.5e-12 1.9e-02 89 TRIM38
26 6 89941356 91704536 1 1 3.8e-14 2.7e-18 7.2e-06 74 BACH2
27 6 107328319 108840870 1 1 1.8e-07 7.3e-07 2.9e-02 80 SCML4
28 6 134905567 136516257 2 2 1.6e-09 1.1e-09 5.9e-02 90 AHI1
29 7 27623776 28468319 1 1 1.0e-09 1.4e-16 2.6e-08 55 JAZF1
30 7 76254810 77744459 1 1 2.2e-07 1.2e-09 8.9e-04 70 GSAP
31 9 4659111 7345375 5 5 1.4e-19 1.0e-36 3.1e-10 75 ERMP1 GLDC KIAA1432 RANBP6
32 9 122881960 124487495 5 1 6.8e-10 7.6e-10 1.0e+00 100 TRAF1
33 9 126321003 127872298 2 1 3.9e-11 8.8e-10 1.0e-02 82 NEK6
34 9 130884753 132281720 1 1 6.9e-08 7.7e-08 2.0e-01 94 ENDOG
35 9 135883620 137326408 2 1 2.8e-16 2.0e-18 1.9e-07 65 ABO
36 10 5238196 7317647 3 3 8.8e-10 4.7e-22 1.9e-14 37 IL2RA PRKCQ
37 10 103527782 105275242 8 1 1.7e-11 1.8e-10 5.4e-01 99 ACTR1A
38 11 36068766 36732916 1 1 9.4e-09 4.7e-10 2.0e-05 53 PRR5L
39 11 61338245 61884025 1 1 2.6e-07 2.1e-06 1.3e-01 90 FADS2
40 11 64669105 66456387 8 2 1.0e-10 7.0e-18 1.5e-01 97 DKFZp761E198 OVOL1
41 11 75204622 77536441 5 4 3.4e-42 3.2e-67 2.1e-17 76 LRRC32 RP11-111M22.3 WNT11
42 11 110721187 112491227 7 1 3.1e-17 6.7e-19 1.0e+00 100 SIK2
43 11 118341649 119751585 2 1 1.7e-08 3.4e-11 3.5e-07 41 NLRX1
44 12 50110317 50601155 1 1 9.5e-08 4.2e-08 3.6e-02 85 AQP5
45 12 52820944 53321436 1 1 7.4e-08 3.1e-06 5.7e-01 98 KRT1
46 12 55601472 58677299 13 3 1.8e-21 1.4e-27 2.3e-02 96 GPR182 STAT6 SUOX
47 12 120502726 122037099 1 1 1.5e-09 4.9e-10 5.9e-03 80 SPPL3
48 12 122713991 124591385 11 1 2.9e-11 5.2e-10 8.2e-01 100 MPHOSPH9
49 13 40440805 41928314 1 1 2.7e-18 5.9e-13 1.4e-02 88 FOXO1
50 13 99155113 100728229 1 2 1.1e-13 1.8e-12 7.4e-03 86 UBAC2
51 14 34820295 36440325 3 1 2.1e-08 3.7e-07 9.9e-02 90 KIAA0391
52 14 92733536 93401178 1 1 5.6e-08 5.9e-07 5.4e-03 69 RIN3
53 15 40778506 42749023 10 1 1.7e-12 2.7e-13 1.5e-03 81 NDUFAF1
54 15 66662107 68492262 3 2 3.6e-28 9.2e-35 5.1e-07 83 AAGAB SMAD3
55 15 90208219 91744509 2 1 4.3e-15 9.5e-13 2.7e-01 98 IQGAP1
56 16 10325245 12138068 6 7 8.2e-32 1.8e-41 NaN NaN CLEC16A DEXI RMI2 RP11-396B14.2 RP11-876N24.5
57 16 26526350 28065536 3 1 3.8e-10 3.2e-11 9.6e-11 5 CTD-3203P2.1
58 17 36710513 39502398 23 3 1.3e-30 3.0e-28 1.0e+00 100 CASC3 KRT222 ORMDL3
59 17 39993748 41393295 3 1 1.3e-08 2.0e-07 2.7e-02 82 RP11-400F19.8
60 17 42628193 43570226 4 1 2.9e-10 1.4e-10 6.7e-02 92 MGC57346
61 17 46668951 48347817 2 1 3.7e-14 4.7e-15 1.0e-02 89 ZNF652
62 18 19692435 21303692 1 1 4.8e-08 1.5e-07 4.7e-01 98 RBBP8
63 18 47706580 49306115 2 1 1.1e-08 3.1e-09 1.1e-01 93 SMAD4
64 18 51100222 52540420 1 1 5.7e-09 2.1e-09 2.2e-05 50 POLI
65 19 2538668 3078394 2 1 1.4e-07 9.0e-07 8.8e-01 100 ZNF554
66 19 16368528 16876099 1 1 2.6e-07 4.1e-07 3.9e-05 34 C19orf44
67 20 51935779 52456445 1 1 1.7e-09 2.8e-13 1.7e-07 49 ZNF217
68 20 61522825 62912463 9 1 1.6e-11 6.4e-11 2.4e-02 88 STMN3
69 21 39849553 41383143 2 1 3.1e-08 2.9e-08 4.7e-06 32 PSMG1
70 22 37063016 37586000 1 1 2.3e-07 1.9e-07 2.5e-01 95 CSF2RB
71 22 40789606 42917154 14 1 3.8e-11 9.0e-10 9.3e-01 100 PHF5A

Pleiotropic Associations

Trait chisq ratio # genes+ # genes++ % genes++ corr corr P genes
Bipolar Disorder or Schizophrenia 1.08 2 1 2.2 0.00 1.0e+00 SF3B1 STAT6
Depressed Affect (Nagel 2018) 0.97 2 0 0.0 0.00 1.0e+00 PHF5A RERE
Depression (Nagel 2018) 1.18 1 1 2.2 0.00 1.0e+00 RERE
Intelligence (Savage-Jansen 2018) 0.93 4 1 2.2 -0.07 9.3e-01 IL18RAP MPHOSPH9 PSMG1 SUOX
Neuroticism (Nagel 2018) 0.95 2 1 2.2 0.00 1.0e+00 PHF5A RERE
Schizophrenia (2018) 1.06 3 0 0.0 0.00 1.0e+00 RERE SF3B1 STAT6
Alzheimer’s Disease (including proxy) 0.98 1 0 0.0 0.00 1.0e+00 PPOX
Crohns Disease (2017) 5.15 17 11 24.4 -0.11 6.4e-01 C5orf56 IL1R1 KIAA0391 KIAA1109 KIAA1841 KIF3A LRRC32 NDFIP1 ORMDL3 PDLIM4 RP11-111M22.3 RP11-373D23.3 SF3B1 SLC22A5 SMAD3 STMN3 TNFSF4
Irritable Bowel Disease (IBD) 4.97 19 13 28.9 -0.35 9.9e-02 BACH2 C5orf56 IL1R1 KIAA0391 KIAA1109 KIAA1841 LINGO4 LRRC32 NDFIP1 ORMDL3 PDLIM4 RGS14 RMI2 RP11-111M22.3 RP11-373D23.3 SLC22A5 SMAD3 STMN3 TNFRSF14
Ulcerative Colitis (UC) 3.18 13 6 13.3 -0.50 5.9e-02 CASC3 IL1R1 KIAA1109 KIAA1841 KRT222 LRRC32 ORMDL3 PDLIM4 RGS14 SLC22A5 SMAD3 STMN3 TNFRSF14
Major Depression (MDD) 0.99 1 0 0.0 0.00 1.0e+00 IL6R
Reaction Time 1.10 1 0 0.0 0.00 1.0e+00 ACTR1A
Verbal and Numeric Reasoning (VNR) 0.93 1 0 0.0 0.00 1.0e+00 SUOX
Breast Cancer 1.72 9 5 11.1 -0.64 6.5e-02 C5orf56 CDC7 DKFZp761E198 FAM114A1 KIF1B OVOL1 RP11-400F19.8 SLC22A5 TLR1
Prostate Cancer 1.37 2 0 0.0 0.00 1.0e+00 ACTR1A IL6R
Coronary Artery Disease (CAD) 1.31 1 0 0.0 0.00 1.0e+00 ABO
Crohns Disease (2012) 4.08 10 6 13.3 -0.02 9.4e-01 C5orf56 LRRC32 NDFIP1 ORMDL3 PDLIM4 RP11-373D23.3 SF3B1 SLC22A5 SMAD3 STMN3
HDL Cholesterol 1.31 2 2 4.4 0.00 1.0e+00 FADS2 ORMDL3
LDL Cholesterol 1.37 2 2 4.4 0.00 1.0e+00 ABO FADS2
Lupus 1.56 2 0 0.0 0.00 1.0e+00 DEXI ORMDL3
Primary Biliary Cirrhosis 2.58 5 5 11.1 0.86 6.5e-02 DEXI IL7R NFKB1 ORMDL3 RMI2
Rheumatoid Arthritis 1.96 1 0 0.0 0.00 1.0e+00 FADS2
Schizophrenia (2014) 1.10 4 1 2.2 -0.44 5.6e-01 MPHOSPH9 RERE SF3B1 STAT6
Triglycerides 1.25 2 2 4.4 0.00 1.0e+00 FADS2 RP11-373D23.3
Type 2 Diabetes (T2D) (2012) 1.45 1 0 0.0 0.00 1.0e+00 JAZF1
Ulcerative Colitis 2.92 8 3 6.7 0.04 9.3e-01 ACTR1A IL1R1 KIAA1109 KIAA1841 ORMDL3 SLC22A5 STMN3 TNFRSF14
Blood Eosinophil Count 16.67 68 61 135.6 -0.86 2.2e-25 AAGAB ABO AHI1 BACH2 C5orf56 CAMK4 CASC3 CD247 CD52 CDC7 CLIC4 CTD-3203P2.1 DEXI DKFZp761E198 ERMP1 FADS2 FAM114A1 FOXO1 GLDC GPR182 IL18RAP IL1R1 IL1RL1 IL2RA IL7R KIAA1109 KIAA1432 KIF1B KIF3A KRT1 KRT222 LCLAT1 LRRC32 MPHOSPH9 NDFIP1 NDUFAF1 NEK6 OVOL1 PDLIM4 PHF5A POLI PPOX PRKCQ RANBP6 RBBP8 RERE RGS14 RIN3 RMI2 RP11-111M22.3 RP11-396B14.2 RP11-876N24.5 SIK2 SLC22A5 SLC25A46 SLC9A2 SMAD3 SMAD4 SPATA5 SPPL3 STAT6 SUOX TNFRSF14 TRAF1 TSLP UBAC2 WDR36 ZNF652
Blood Platelet Count 1.81 26 26 57.8 -0.24 2.3e-01 ACTR1A C5orf56 CD52 CDC7 CLIC4 FADS2 FAM208A FOXO1 IL6R KIF1B KIF3A MPHOSPH9 NDFIP1 NLRX1 ORMDL3 OVOL1 PDLIM4 PHF5A PSMG1 SF3B1 SIK2 SLC22A5 SPPL3 STMN3 TRAF1 ZNF554
Blood Red Count 1.36 20 15 33.3 0.26 2.5e-01 ABO AHI1 BACH2 CLIC4 CSF2RB FADS2 FAM114A1 FAM208A FOXO1 LINGO4 MGC57346 NDFIP1 NDUFAF1 NFKB1 POLI RGS14 SF3B1 SUOX TLR1 ZNF217
Blood White Count 3.77 35 22 48.9 -0.33 3.5e-02 ABO ACTR1A AHI1 BACH2 C19orf44 C5orf56 CASC3 CDC7 DEXI FADS2 GSAP IL1RL1 IQGAP1 KIAA1841 KIF3A MGC57346 NDFIP1 ORMDL3 PDLIM4 POLI PPOX RERE RGS14 RIN3 RP11-373D23.3 RP11-396B14.2 RP11-400F19.8 RP11-876N24.5 SCML4 SLC22A5 SPPL3 STMN3 TRAF1 ZNF217 ZNF652
Heel T-Score 1.22 14 11 24.4 0.08 8.0e-01 AAGAB ABO ERMP1 FADS2 FAM208A IQGAP1 KIF1B LCLAT1 MPHOSPH9 NEK6 OVOL1 RERE RIN3 ZNF554
BMI 0.86 7 4 8.9 0.57 1.8e-01 AAGAB NEK6 PSMG1 RP11-400F19.8 SUOX TLR1 TNFRSF14
Height 1.30 28 22 48.9 0.42 1.9e-02 AAGAB ABO ACTR1A C5orf56 CD52 DKFZp761E198 FADS2 FAM208A IL18RAP IL1R1 IQGAP1 KIAA1109 KIF1B KIF3A MPHOSPH9 NDUFAF1 NFKB1 PDLIM4 PHF5A RBBP8 RERE RGS14 RP11-373D23.3 SLC22A5 SPPL3 STAT6 ZNF554 ZNF652
Waist Hip Ratio (WHR) 1.08 10 3 6.7 0.28 4.1e-01 AAGAB CLEC16A ENDOG GSAP MPHOSPH9 RBBP8 RP11-396B14.2 RP11-876N24.5 SF3B1 SIK2
Systolic Blood Pressure 1.00 9 7 15.6 -0.59 7.3e-02 CLIC4 FAM208A MGC57346 NDUFAF1 RERE RP11-111M22.3 RP11-373D23.3 SIK2 ZNF652
Smoking Status 1.36 5 3 6.7 0.18 7.7e-01 ACTR1A PHF5A RERE SUOX ZNF652
Allergy or Eczema 25.95 92 80 177.8 -0.99 2.1e-91 AAGAB ABO AC008781.7 ACTR1A AHI1 AQP5 BACH2 C5orf56 CAMK4 CASC3 CD247 CLEC16A CLIC4 CSF2RB CTD-3203P2.1 DEXI DKFZp761E198 ENDOG ERMP1 FAM114A1 FAM208A FOXO1 GLDC GPR182 GSAP IL18RAP IL1R1 IL1RL1 IL2RA IL6R IL7R IQGAP1 JAZF1 KIAA0391 KIAA1109 KIAA1432 KIAA1841 KIF3A KRT222 LCLAT1 LINGO4 LRRC32 MGC57346 MPHOSPH9 NDFIP1 NDUFAF1 NEK6 NFKB1 ORMDL3 OVOL1 PHF5A POLI PPOX PRKCQ PRR5L PSMG1 RANBP6 RBBP8 RERE RGS14 RIN3 RMI2 RP11-111M22.3 RP11-373D23.3 RP11-396B14.2 RP11-400F19.8 RP11-876N24.5 S100A11 SCML4 SF3B1 SIK2 SLC22A5 SLC25A46 SLC9A2 SMAD3 SMAD4 SPATA5 SPPL3 STAT6 STMN3 SUOX TLR1 TMEM232 TNFRSF14 TNFSF4 TRAF1 TSLP UBAC2 WDR36 WNT11 ZNF217 ZNF652
Cardiovascular Disease 1.47 11 4 8.9 -0.19 5.8e-01 AAGAB C5orf56 CLIC4 KRT222 NDUFAF1 RERE RP11-111M22.3 SIK2 SLC22A5 SUOX ZNF652
Hypothyroidism (self reported) 2.52 14 5 11.1 -0.03 9.2e-01 AHI1 BACH2 CD247 ENDOG FADS2 IL7R KIAA1109 NEK6 RERE SPPL3 SUOX TLR1 TRAF1 UBAC2
Respiratory disease 18.96 72 48 106.7 -0.96 1.4e-51 AAGAB AC008781.7 AHI1 BACH2 C5orf56 CASC3 CD247 CTD-3203P2.1 DEXI DKFZp761E198 ERMP1 FADS2 FAM114A1 FAM208A FOXO1 GLDC GPR182 IL18RAP IL1R1 IL1RL1 IL2RA IL7R JAZF1 KIAA1109 KIAA1432 KIF1B KIF3A KRT222 LINGO4 LRRC32 MGC57346 MPHOSPH9 NDFIP1 NDUFAF1 NEK6 ORMDL3 PDLIM4 PHF5A POLI PPOX PRKCQ PSMG1 RANBP6 RERE RGS14 RIN3 RMI2 RP11-111M22.3 RP11-396B14.2 RP11-400F19.8 RP11-876N24.5 S100A11 SCML4 SIK2 SLC22A5 SLC25A46 SLC9A2 SMAD3 SPATA5 SPPL3 STAT6 STMN3 SUOX TLR1 TMEM232 TNFSF4 TRAF1 TSLP UBAC2 WDR36 ZNF217 ZNF652
Type 2 Diabetes (T2D) (2018) 1.07 1 0 0.0 0.00 1.0e+00 JAZF1
Lung FEV1/FVC ratio 2.20 22 12 26.7 0.84 1.4e-07 ABO AQP5 BACH2 FOXO1 GLDC IL1R1 IL1RL1 IL7R KIAA1432 ORMDL3 PDLIM4 PRKCQ RBBP8 RERE RGS14 RP11-396B14.2 SLC22A5 SLC9A2 SMAD3 STAT6 SUOX ZNF652
Lung FVC 1.50 13 10 22.2 0.19 5.1e-01 AAGAB ABO AHI1 C5orf56 KIF1B LINGO4 MPHOSPH9 RBBP8 RIN3 SLC22A5 SPPL3 STMN3 SUOX
Neuroticism 0.80 2 1 2.2 0.00 1.0e+00 AAGAB RERE
Chronotype (morning person) 1.20 2 0 0.0 0.00 1.0e+00 KIAA1109 SF3B1
Hair Pigment 0.19 8 6 13.3 -0.42 2.6e-01 AHI1 FADS2 JAZF1 KIAA1432 KIF1B MPHOSPH9 RP11-373D23.3 SUOX
Tanning 0.20 1 0 0.0 0.00 1.0e+00 RP11-373D23.3
Hand grip strength (left) 1.23 5 3 6.7 0.99 6.3e-04 ACTR1A C5orf56 KIF1B PDLIM4 SLC22A5
Number of treatments/medications taken 2.12 3 1 2.2 0.00 1.0e+00 NDUFAF1 SLC9A2 ZNF652
Frequency of depressed mood in last 2 weeks 1.12 1 0 0.0 0.00 1.0e+00 RERE
Relative age of first facial hair 1.06 2 1 2.2 0.00 1.0e+00 PSMG1 SPPL3
Ever used hormone-replacement therapy (HRT) 1.20 1 0 0.0 0.00 1.0e+00 NEK6
Systolic blood pressure, automated reading 0.98 3 2 4.4 0.00 1.0e+00 MGC57346 NDUFAF1 RERE
Angina 1.09 1 1 2.2 0.00 1.0e+00 ZNF652
Vitamin and mineral supplements 1.38 1 1 2.2 0.00 1.0e+00 STAT6
Medication: Metformin 1.40 1 0 0.0 0.00 1.0e+00 ABO
Severe depression (siblings) 1.29 1 0 0.0 0.00 1.0e+00 IL18RAP
Impedance of leg (right) 1.18 7 4 8.9 -0.59 1.6e-01 AQP5 RIN3 RP11-400F19.8 SF3B1 SUOX TNFRSF14 ZNF652
Leg fat-free mass (left) 1.10 13 7 15.6 0.71 6.9e-03 ACTR1A FAM208A FOXO1 MPHOSPH9 NLRX1 PDLIM4 RIN3 RP11-373D23.3 RP11-400F19.8 SLC22A5 SUOX TNFRSF14 TRIM38
Trunk fat percentage 1.12 8 5 11.1 -0.27 5.1e-01 AAGAB ABO PHF5A PSMG1 RERE RP11-400F19.8 SF3B1 TRIM38
Hand grip strength (right) 1.34 6 3 6.7 0.79 1.9e-02 ACTR1A C5orf56 IL1R1 KIF1B PDLIM4 SLC22A5
Current tobacco smoking 1.25 2 1 2.2 0.00 1.0e+00 PHF5A STMN3
Relative age voice broke 1.08 1 0 0.0 0.00 1.0e+00 PSMG1
Taking other prescription medications 3.07 3 3 6.7 -0.91 9.5e-02 IL1RL1 ORMDL3 ZNF652
Age when periods started (menarche) 1.38 4 1 2.2 -0.65 3.5e-01 PDLIM4 PSMG1 SPPL3 SUOX
Heel bone mineral density (BMD) T-score, automated (left) 1.06 2 2 4.4 0.00 1.0e+00 IQGAP1 RERE
High blood pressure 1.56 9 4 8.9 -0.07 8.6e-01 AAGAB ABO NDUFAF1 POLI RERE SIK2 SLC22A5 SUOX ZNF652
Hayfever, allergic rhinitis or eczema 24.05 94 75 166.7 -0.99 1.7e-102 AC008781.7 ACTR1A AHI1 AQP5 BACH2 C5orf56 CAMK4 CD247 CD52 CDC7 CLEC16A CLIC4 CSF2RB CTD-3203P2.1 DEXI DKFZp761E198 ENDOG ERMP1 FAM114A1 FAM208A FOXO1 GLDC GPR182 GSAP IL18RAP IL1R1 IL1RL1 IL2RA IL6R IL7R IQGAP1 JAZF1 KIAA0391 KIAA1109 KIAA1432 KIAA1841 KIF3A KRT222 LCLAT1 LINGO4 LRRC32 MGC57346 MPHOSPH9 NDFIP1 NDUFAF1 NEK6 NFKB1 NLRX1 ORMDL3 OVOL1 PHF5A POLI PPOX PRKCQ PRR5L PSMG1 RANBP6 RBBP8 RERE RGS14 RIN3 RMI2 RP11-111M22.3 RP11-373D23.3 RP11-396B14.2 RP11-400F19.8 RP11-876N24.5 S100A11 SCML4 SF3B1 SIK2 SLC22A5 SLC25A46 SLC9A2 SMAD3 SMAD4 SPATA5 SPPL3 STAT6 STMN3 SUOX TLR1 TMEM232 TNFRSF14 TNFSF4 TRAF1 TRIM38 TSLP UBAC2 WDR36 WNT11 ZNF217 ZNF554 ZNF652
Multivitamins +/- minerals 1.27 1 0 0.0 0.00 1.0e+00 STAT6
Medication: Levothyroxine sodium 2.16 5 2 4.4 0.75 1.4e-01 AHI1 BACH2 FADS2 IL7R SUOX
Sitting height 1.24 14 8 17.8 0.60 1.8e-02 ACTR1A CD52 FAM114A1 FAM208A KIAA1109 MPHOSPH9 NDUFAF1 NLRX1 PDLIM4 RGS14 SLC22A5 STAT6 TRIM38 ZNF652
Body mass index (BMI) 0.95 5 4 8.9 0.99 1.0e-03 PSMG1 RP11-400F19.8 SUOX TNFRSF14 TRIM38
Impedance of leg (left) 1.15 7 4 8.9 -0.54 2.1e-01 RIN3 RP11-400F19.8 S100A11 SF3B1 SUOX TNFRSF14 ZNF652
Leg predicted mass (left) 1.11 14 7 15.6 0.72 3.8e-03 ACTR1A FAM208A FOXO1 MPHOSPH9 NLRX1 PDLIM4 RIN3 RP11-373D23.3 RP11-400F19.8 SF3B1 SLC22A5 SUOX TNFRSF14 TRIM38
Trunk fat mass 0.99 6 2 4.4 -0.01 9.9e-01 AAGAB PHF5A RERE RP11-400F19.8 TNFRSF14 TRIM38
Waist circumference 1.00 7 3 6.7 0.75 5.2e-02 AAGAB FOXO1 RP11-373D23.3 RP11-400F19.8 SUOX TNFRSF14 TRIM38
Past tobacco smoking 1.35 3 1 2.2 0.00 1.0e+00 AAGAB ACTR1A PSMG1
Hearing difficulty/problems with background noise 1.07 1 0 0.0 0.00 1.0e+00 ACTR1A
Hair/balding pattern: Pattern 2 1.27 1 0 0.0 0.00 1.0e+00 CLIC4
Forced vital capacity (FVC) 1.04 5 3 6.7 0.69 8.5e-02 AAGAB ACTR1A AHI1 LINGO4 STMN3
Heel bone mineral density (BMD) T-score, automated (right) 1.15 3 2 4.4 0.00 1.0e+00 FADS2 IQGAP1 RERE
Qualifications: None of the above 1.10 3 2 4.4 0.00 1.0e+00 FAM208A MPHOSPH9 SUOX
Heart attack 1.11 1 0 0.0 0.00 1.0e+00 ZNF652
Hayfever/allergic rhinitis (self-reported) 11.02 29 14 31.1 -0.99 1.3e-27 BACH2 CD247 DEXI FAM114A1 GLDC GPR182 IL18RAP IL1RL1 IL7R IQGAP1 KIAA1109 KRT222 LRRC32 ORMDL3 PPOX RANBP6 RP11-396B14.2 RP11-876N24.5 SLC25A46 SLC9A2 SMAD3 SPATA5 STAT6 SUOX TLR1 TMEM232 TNFSF4 TSLP WDR36
Medication: Simvastatin 1.19 2 0 0.0 0.00 1.0e+00 ABO NDUFAF1
Fluid intelligence score 1.13 2 0 0.0 0.00 1.0e+00 MPHOSPH9 SUOX
Neuroticism score 0.77 2 0 0.0 0.00 1.0e+00 PHF5A RERE
Weight 1.03 11 6 13.3 0.54 8.3e-02 AAGAB ACTR1A FAM208A FOXO1 NLRX1 RP11-373D23.3 RP11-400F19.8 SLC22A5 SUOX TNFRSF14 TRIM38
Impedance of arm (right) 1.76 17 9 20.0 -0.53 2.8e-02 AAGAB ABO ERMP1 KIF1B LCLAT1 LRRC32 NEK6 NLRX1 ORMDL3 OVOL1 PHF5A RIN3 RP11-373D23.3 SF3B1 SUOX TNFRSF14 ZNF652
Arm fat percentage (right) 1.01 7 3 6.7 -0.01 9.8e-01 AAGAB ABO RERE RP11-400F19.8 SUOX TNFRSF14 TRIM38
Trunk fat-free mass 1.39 16 12 26.7 0.55 2.6e-02 ABO ACTR1A DKFZp761E198 FAM208A MPHOSPH9 NDUFAF1 NEK6 NLRX1 RBBP8 RIN3 RP11-373D23.3 SF3B1 SLC22A5 STAT6 SUOX TRIM38
Hip circumference 0.94 6 1 2.2 0.68 1.4e-01 FOXO1 NLRX1 PSMG1 RP11-373D23.3 SUOX TRIM38
Father's age at death 1.51 2 0 0.0 0.00 1.0e+00 ABO SLC22A5
Worrier / anxious feelings 0.82 1 0 0.0 0.00 1.0e+00 ACTR1A
Hair/balding pattern: Pattern 3 0.99 1 0 0.0 0.00 1.0e+00 CLIC4
Number of live births 1.22 1 0 0.0 0.00 1.0e+00 NFKB1
Forced expiratory volume in 1-second (FEV1) 1.15 5 0 0.0 0.99 1.7e-03 ABO AHI1 LINGO4 STMN3 SUOX
Pulse rate 1.07 1 0 0.0 0.00 1.0e+00 FADS2
Qualifications: A levels/AS levels or equivalent 1.01 2 1 2.2 0.00 1.0e+00 MPHOSPH9 SUOX
Mouth/teeth dental problems: Dentures 1.34 2 0 0.0 0.00 1.0e+00 C5orf56 PPOX
Asthma 19.72 65 47 104.4 -0.97 5.9e-51 AAGAB AHI1 BACH2 C5orf56 CASC3 CD247 CD52 CTD-3203P2.1 DEXI DKFZp761E198 ERMP1 FADS2 FAM114A1 FAM208A GLDC GPR182 IL18RAP IL1R1 IL1RL1 IL7R JAZF1 KIAA1109 KIAA1432 KIF1B KIF3A KRT222 LINGO4 LRRC32 MGC57346 NDFIP1 NDUFAF1 ORMDL3 PDLIM4 PHF5A POLI PPOX PRKCQ RANBP6 RERE RGS14 RIN3 RMI2 RP11-111M22.3 RP11-396B14.2 RP11-400F19.8 RP11-876N24.5 S100A11 SCML4 SIK2 SLC22A5 SLC25A46 SLC9A2 SMAD3 SMAD4 SPPL3 STAT6 SUOX TLR1 TMEM232 TNFSF4 TSLP UBAC2 WDR36 WNT11 ZNF652
Medication: Ibuprofen (e.g. Nurofen) 1.27 1 1 2.2 0.00 1.0e+00 STAT6
Medication: Cholesterol lowering 0.98 2 0 0.0 0.00 1.0e+00 ABO NDUFAF1
Depression (self-reported) 1.09 1 0 0.0 0.00 1.0e+00 RERE
Forced expiratory volume in 1-second (FEV1), Best measure 1.23 4 0 0.0 1.00 1.9e-03 ABO SLC22A5 STMN3 SUOX
Impedance of arm (left) 1.77 14 9 20.0 -0.45 1.1e-01 ABO DEXI KIF1B LCLAT1 LRRC32 NEK6 NLRX1 OVOL1 PHF5A RIN3 RP11-373D23.3 SF3B1 SUOX ZNF652
Arm fat mass (right) 0.93 8 4 8.9 0.64 8.8e-02 AAGAB FOXO1 NLRX1 PSMG1 RP11-400F19.8 SUOX TNFRSF14 TRIM38
Trunk predicted mass 1.40 16 12 26.7 0.55 2.6e-02 ABO ACTR1A DKFZp761E198 FAM208A MPHOSPH9 NDUFAF1 NEK6 NLRX1 RBBP8 RIN3 RP11-373D23.3 SF3B1 SLC22A5 STAT6 SUOX TRIM38
Standing height 1.43 22 18 40.0 0.46 2.4e-02 AAGAB ACTR1A C5orf56 CD52 DKFZp761E198 FADS2 FAM208A IL1R1 IQGAP1 MPHOSPH9 NDUFAF1 NLRX1 PDLIM4 PHF5A RBBP8 RGS14 RP11-373D23.3 SLC22A5 SPPL3 STAT6 TRIM38 ZNF652
Breastfed as a baby 1.25 1 0 0.0 0.00 1.0e+00 MPHOSPH9
Tense / 'highly strung' 0.99 1 1 2.2 0.00 1.0e+00 RERE
Hair/balding pattern: Pattern 4 1.77 5 3 6.7 0.13 8.3e-01 CLIC4 IQGAP1 KIF1B MGC57346 S100A11
Birth weight of first child 1.28 1 0 0.0 0.00 1.0e+00 SUOX
Peak expiratory flow (PEF) 1.05 2 1 2.2 0.00 1.0e+00 ABO ACTR1A
Qualifications: O levels/GCSEs or equivalent 1.03 1 1 2.2 0.00 1.0e+00 MPHOSPH9
Blood clot in the leg (DVT) 2.77 1 1 2.2 0.00 1.0e+00 ABO
Medication: Paracetamol 1.34 1 1 2.2 0.00 1.0e+00 STAT6
Headache pain in last month 1.55 2 1 2.2 0.00 1.0e+00 STAT6 SUOX
Medication for cholesterol, blood pressure or diabetes 1.35 3 1 2.2 0.00 1.0e+00 NDUFAF1 SIK2 ZNF652
Gout (self-reported) 1.42 1 0 0.0 0.00 1.0e+00 OVOL1
Hypothyroidism/myxoedema (self-reported) 2.32 8 3 6.7 0.35 3.9e-01 AHI1 BACH2 CD247 FADS2 KIAA1109 NEK6 RERE SUOX
Medication: Ventolin 100micrograms inhaler 8.84 19 7 15.6 -0.96 1.8e-12 AAGAB AHI1 BACH2 CD247 FOXO1 GLDC IL18RAP IL1RL1 KIAA1109 LRRC32 NDFIP1 ORMDL3 SLC22A5 SLC9A2 SMAD3 STAT6 SUOX TLR1 ZNF652
Birth weight 1.26 3 0 0.0 0.00 1.0e+00 NFKB1 SIK2 TRAF1
Forced vital capacity (FVC), Best measure 0.99 5 2 4.4 0.70 1.2e-01 AAGAB ACTR1A AHI1 LINGO4 STMN3
Body fat percentage 1.11 7 3 6.7 -0.18 7.0e-01 AAGAB ABO PHF5A PSMG1 RERE RP11-400F19.8 TRIM38
Leg fat percentage (right) 1.14 6 3 6.7 0.25 6.3e-01 AAGAB FADS2 KRT222 RERE RP11-400F19.8 TRIM38
Arm fat-free mass (right) 1.38 14 10 22.2 0.51 6.1e-02 ABO ACTR1A DKFZp761E198 FAM208A MPHOSPH9 NEK6 NLRX1 RBBP8 RIN3 RP11-373D23.3 SF3B1 SLC22A5 SUOX TRIM38
Comparative body size at age 10 1.18 2 1 2.2 0.00 1.0e+00 OVOL1 ZNF652
Worry too long after embarrassment 0.98 1 0 0.0 0.00 1.0e+00 AHI1
Wheeze or whistling in the chest in last year 7.53 27 13 28.9 -0.98 5.2e-23 BACH2 CASC3 CD247 DEXI FADS2 GLDC GPR182 IL1RL1 KIAA1109 KIAA1432 LRRC32 ORMDL3 RERE RIN3 RMI2 RP11-396B14.2 RP11-876N24.5 SIK2 SLC22A5 SLC25A46 SLC9A2 SMAD3 STMN3 TSLP UBAC2 WDR36 ZNF652
Age at first live birth 1.13 1 0 0.0 0.00 1.0e+00 SUOX
Shortness of breath walking on level ground 1.21 1 0 0.0 0.00 1.0e+00 LRRC32
Qualifications: College or University degree 1.09 3 2 4.4 0.00 1.0e+00 MPHOSPH9 SUOX TRIM38
Medication for pain relief, constipation, heartburn 1.33 2 1 2.2 0.00 1.0e+00 MPHOSPH9 STAT6
Neck or shoulder pain in last month 1.12 1 0 0.0 0.00 1.0e+00 SUOX
Medication: Blood pressure 1.52 2 2 4.4 0.00 1.0e+00 SIK2 ZNF652
Angina (self-reported) 1.01 1 0 0.0 0.00 1.0e+00 ZNF652
Migraine (self-reported) 1.52 1 1 2.2 0.00 1.0e+00 STAT6
Medication: Ibuprofen 1.18 1 1 2.2 0.00 1.0e+00 STAT6
Medication: Allopurinol 1.32 1 0 0.0 0.00 1.0e+00 OVOL1
Medication: Seretide 50 evohaler 4.08 4 0 0.0 -0.93 8.0e-03 IL1RL1 SLC22A5 SMAD3 ZNF652
Whole body fat mass 0.99 9 3 6.7 0.08 8.4e-01 AAGAB NLRX1 PHF5A PSMG1 RERE RP11-400F19.8 SUOX TNFRSF14 TRIM38
Leg fat mass (right) 1.00 9 3 6.7 0.34 3.7e-01 AAGAB NLRX1 PSMG1 RERE RP11-373D23.3 RP11-400F19.8 SUOX TNFRSF14 TRIM38
Arm predicted mass (right) 1.40 14 11 24.4 0.51 6.4e-02 ABO ACTR1A DKFZp761E198 FAM208A MPHOSPH9 NEK6 NLRX1 RBBP8 RIN3 RP11-373D23.3 SF3B1 SLC22A5 SUOX TRIM38
Pulse rate, automated reading 1.22 4 1 2.2 0.44 5.6e-01 ABO FADS2 SIK2 SUOX
Alcohol intake frequency. 1.20 3 0 0.0 0.00 1.0e+00 NFKB1 STAT6 SUOX
Comparative height size at age 10 1.20 11 8 17.8 0.64 2.6e-02 AAGAB ACTR1A C5orf56 DKFZp761E198 IQGAP1 MPHOSPH9 NLRX1 PDLIM4 RBBP8 SLC22A5 TRIM38
Suffer from 'nerves' 0.98 1 0 0.0 0.00 1.0e+00 RERE
Overall health rating 1.01 2 1 2.2 0.00 1.0e+00 SF3B1 ZNF652
Chest pain or discomfort 1.40 1 0 0.0 0.00 1.0e+00 IL1RL1
Had major operations 1.29 1 0 0.0 0.00 1.0e+00 ZNF652
Supplements: Vitamin C 1.02 1 0 0.0 0.00 1.0e+00 ORMDL3
Knee pain experienced in last month 1.35 1 0 0.0 0.00 1.0e+00 RP11-396B14.2
Hypertension (Self-reported) 1.60 10 4 8.9 -0.01 9.7e-01 ABO CLIC4 NDUFAF1 PDLIM4 POLI RERE SIK2 SLC22A5 SUOX ZNF652
Illnesses of father: Heart disease 1.32 2 0 0.0 0.00 1.0e+00 ABO SIK2
Forced expiratory volume in 1-second (FEV1), predicted 1.24 2 1 2.2 0.00 1.0e+00 ACTR1A SLC22A5
Whole body fat-free mass 1.28 15 10 22.2 0.63 1.2e-02 ACTR1A DKFZp761E198 FAM208A MPHOSPH9 NDUFAF1 NLRX1 PDLIM4 RBBP8 RIN3 RP11-373D23.3 SF3B1 SLC22A5 STAT6 SUOX TRIM38
Leg fat-free mass (right) 1.11 13 7 15.6 0.71 6.1e-03 ACTR1A FAM208A MPHOSPH9 NLRX1 PDLIM4 RIN3 RP11-373D23.3 RP11-400F19.8 SF3B1 SLC22A5 SUOX TNFRSF14 TRIM38
Arm fat percentage (left) 1.01 8 4 8.9 -0.12 7.7e-01 AAGAB ABO PHF5A PSMG1 RERE RP11-400F19.8 TNFRSF14 TRIM38
Mood swings 0.87 1 0 0.0 0.00 1.0e+00 PHF5A
Loneliness, isolation 0.90 1 0 0.0 0.00 1.0e+00 RERE
Long-standing illness, disability or infirmity 1.71 1 0 0.0 0.00 1.0e+00 ZNF652
Ever had bowel cancer screening 1.35 1 0 0.0 0.00 1.0e+00 SIK2
Diabetes diagnosed by doctor 1.20 1 0 0.0 0.00 1.0e+00 JAZF1
Qualifications: nursing, teaching 1.03 1 0 0.0 0.00 1.0e+00 MPHOSPH9
Mouth/teeth dental problems: Mouth ulcers 1.75 1 0 0.0 0.00 1.0e+00 NFKB1
Asthma (self-reported) 19.39 68 49 108.9 -0.97 2.8e-52 AAGAB AHI1 BACH2 C5orf56 CASC3 CD247 CD52 CTD-3203P2.1 DEXI DKFZp761E198 ERMP1 FADS2 FAM114A1 FAM208A GLDC GPR182 IL18RAP IL1R1 IL1RL1 IL7R JAZF1 KIAA1109 KIAA1432 KIF1B KIF3A KRT222 LINGO4 LRRC32 MGC57346 NDFIP1 NDUFAF1 NEK6 ORMDL3 OVOL1 PDLIM4 PHF5A POLI PPOX PRKCQ RANBP6 RERE RGS14 RIN3 RMI2 RP11-111M22.3 RP11-396B14.2 RP11-400F19.8 RP11-876N24.5 S100A11 SCML4 SIK2 SLC22A5 SLC25A46 SLC9A2 SMAD3 SMAD4 SPATA5 SPPL3 STAT6 SUOX TLR1 TMEM232 TNFSF4 TSLP UBAC2 WDR36 WNT11 ZNF652
Medication: Aspirin 1.31 1 0 0.0 0.00 1.0e+00 SIK2
Smoking status: Current 1.23 1 1 2.2 0.00 1.0e+00 PHF5A
Forced expiratory volume in 1-second (FEV1), predicted percentage 1.37 2 0 0.0 0.00 1.0e+00 ORMDL3 STMN3
Whole body water mass 1.29 14 10 22.2 0.61 2.1e-02 ACTR1A DKFZp761E198 FAM208A MPHOSPH9 NLRX1 PDLIM4 RBBP8 RIN3 RP11-373D23.3 SF3B1 SLC22A5 STAT6 SUOX TRIM38
Leg predicted mass (right) 1.12 13 7 15.6 0.72 5.9e-03 ACTR1A FAM208A MPHOSPH9 NLRX1 PDLIM4 RIN3 RP11-373D23.3 RP11-400F19.8 SF3B1 SLC22A5 SUOX TNFRSF14 TRIM38
Arm fat mass (left) 0.95 9 5 11.1 0.41 2.8e-01 AAGAB FOXO1 NLRX1 PSMG1 RERE RP11-400F19.8 SUOX TNFRSF14 TRIM38
Number of self-reported non-cancer illnesses 3.92 10 3 6.7 -0.91 4.1e-05 AAGAB IL1RL1 LINGO4 LRRC32 ORMDL3 RGS14 RP11-396B14.2 RP11-876N24.5 SLC22A5 ZNF652
Medication: Blood pressure 1.41 3 0 0.0 0.00 1.0e+00 NDUFAF1 SIK2 SLC22A5
High cholesterol (Self-reported) 1.09 1 1 2.2 0.00 1.0e+00 ABO
Medication: Paracetamol 1.15 1 1 2.2 0.00 1.0e+00 STAT6
Medication: Atorvastatin 1.26 1 0 0.0 0.00 1.0e+00 ABO
Alcohol drinker status: Never 1.27 1 0 0.0 0.00 1.0e+00 SLC9A2
Ever smoked 1.31 2 0 0.0 0.00 1.0e+00 ACTR1A PSMG1
Basal metabolic rate 1.21 15 8 17.8 0.63 1.3e-02 ACTR1A DKFZp761E198 FAM208A FOXO1 MPHOSPH9 NLRX1 RBBP8 RIN3 RP11-373D23.3 RP11-400F19.8 SF3B1 SLC22A5 SUOX TNFRSF14 TRIM38
Leg fat percentage (left) 1.13 6 2 4.4 -0.01 9.9e-01 AAGAB KRT222 MPHOSPH9 RERE RP11-400F19.8 TRIM38
Arm fat-free mass (left) 1.38 13 10 22.2 0.47 1.0e-01 ABO ACTR1A FAM208A MPHOSPH9 NEK6 NLRX1 RBBP8 RIN3 RP11-373D23.3 SF3B1 SLC22A5 SUOX TRIM38
Number of operations (self-reported) 1.76 1 0 0.0 0.00 1.0e+00 DEXI
Fractured/broken bones in last 5 years 1.21 1 0 0.0 0.00 1.0e+00 AAGAB
Diastolic blood pressure, automated reading 1.60 9 5 11.1 -0.29 4.6e-01 AAGAB ABO CLIC4 MPHOSPH9 NDUFAF1 RERE STMN3 SUOX ZNF652
Unable to work because of sickness or disability 0.86 1 0 0.0 0.00 1.0e+00 SF3B1
Myopia 1.17 1 0 0.0 0.00 1.0e+00 STAT6
Vascular/heart problems diagnosed by doctor 1.63 8 4 8.9 0.30 4.3e-01 AAGAB ABO NDUFAF1 RERE SIK2 SLC22A5 SUOX ZNF652
Cholesterol lowering medication 1.16 1 1 2.2 0.00 1.0e+00 ABO
Pain experienced in last month 1.21 2 1 2.2 0.00 1.0e+00 STAT6 SUOX
Heart attack/myocardial infarction (self-reported) 1.17 1 0 0.0 0.00 1.0e+00 ZNF652
Deep venous thrombosis (DVT) (self-reported) 2.76 1 1 2.2 0.00 1.0e+00 ABO
Impedance of whole body 1.45 12 7 15.6 -0.44 1.5e-01 DEXI ERMP1 KIF1B LRRC32 NEK6 PHF5A RIN3 RP11-400F19.8 SF3B1 SUOX TNFRSF14 ZNF652
Leg fat mass (left) 0.99 9 3 6.7 0.35 3.6e-01 AAGAB NLRX1 PSMG1 RERE RP11-373D23.3 RP11-400F19.8 SUOX TNFRSF14 TRIM38
Arm predicted mass (left) 1.40 14 10 22.2 0.50 6.6e-02 ABO ACTR1A FAM208A FOXO1 MPHOSPH9 NEK6 NLRX1 RBBP8 RIN3 RP11-373D23.3 SF3B1 SLC22A5 SUOX TRIM38

Associations by panel

study tissue # hits % hits/tests avg chisq
GTEx Adipose Subcutaneous 21 0.60 2.2
GTEx Adipose Visceral Omentum 18 0.88 2.3
GTEx Adrenal Gland 10 0.69 2.1
GTEx Artery Aorta 23 0.77 2.2
GTEx Artery Coronary 4 0.34 2.1
GTEx Artery Tibial 26 0.69 2.3
GTEx Brain Caudate basal ganglia 5 0.54 2.0
GTEx Brain Cerebellar Hemisphere 10 0.67 2.3
GTEx Brain Cerebellum 14 0.71 2.3
GTEx Brain Cortex 7 0.68 2.4
GTEx Brain Frontal Cortex BA9 10 1.08 2.3
GTEx Brain Hippocampus 3 0.57 1.9
GTEx Brain Hypothalamus 8 1.36 2.3
GTEx Brain Nucleus accumbens basal ganglia 11 1.27 2.4
GTEx Brain Putamen basal ganglia 7 1.12 2.3
GTEx Breast Mammary Tissue 21 1.06 2.5
GTEx Breast Mammary Tissue (Male) 9 0.75 2.5
GTEx Breast Mammary Tissue (Female) 16 0.97 2.4
GTEx Cells EBV-transformed lymphocytes 9 0.63 2.0
GTEx Cells Transformed fibroblasts 39 0.93 2.4
GTEx Colon Sigmoid 10 0.68 2.3
GTEx Colon Transverse 20 0.97 2.4
GTEx Esophagus Gastroesophageal Junction 9 0.62 2.3
GTEx Esophagus Mucosa 27 0.81 2.4
GTEx Esophagus Muscularis 25 0.77 2.3
GTEx Heart Atrial Appendage 9 0.57 2.3
GTEx Heart Left Ventricle 8 0.52 1.9
GTEx Liver 5 0.70 2.2
GTEx Lung 18 0.63 2.2
GTEx Muscle Skeletal 19 0.66 2.2
GTEx Nerve Tibial 29 0.67 2.2
GTEx Ovary 7 0.77 2.2
GTEx Pancreas 16 0.98 2.5
GTEx Pituitary 11 0.99 2.2
GTEx Prostate 6 0.72 2.2
GTEx Skin Not Sun Exposed Suprapubic 28 1.14 2.4
GTEx Skin Sun Exposed Lower leg 32 0.88 2.3
GTEx Small Intestine Terminal Ileum 1 0.22 2.1
GTEx Spleen 13 0.92 2.4
GTEx Stomach 12 0.83 2.1
GTEx Testis 28 0.89 2.4
GTEx Thyroid 34 0.85 2.4
GTEx Uterus 4 0.71 2.3
GTEx Vagina 4 0.63 2.1
GTEx Whole Blood 18 0.90 2.5
METSIM Adipose 36 0.78 2.3
NTR Blood 22 0.92 2.5
ROSMAP Brain Pre-frontal Cortex 23 0.52 2.2
YFS Blood 43 0.93 2.5
CommonMind Brain Pre-frontal Cortex 41 0.76 2.2
The Cancer Genome Atlas Bladder Urothelial Carcinoma 14 0.85 2.4
The Cancer Genome Atlas Breast Invasive Carcinoma 37 0.84 2.3
The Cancer Genome Atlas Cervical Squamous Cell Carcinoma 7 0.64 2.2
The Cancer Genome Atlas Colon Adenocarcinoma 19 0.92 2.4
The Cancer Genome Atlas Esophageal Carcinoma 5 0.73 2.2
The Cancer Genome Atlas Glioblastoma Multiforme 9 0.88 2.3
The Cancer Genome Atlas Head and Neck Squamous Cell Carcinoma 23 0.84 2.4
The Cancer Genome Atlas Kidney Renal Clear Cell Carcinoma 30 0.73 2.4
The Cancer Genome Atlas Kidney Renal Papillary Cell Carcinoma 16 0.78 2.5
The Cancer Genome Atlas Brain Lower Grade Glioma 27 0.63 2.2
The Cancer Genome Atlas Liver Hepatocellular Carcinoma 7 0.63 2.4
The Cancer Genome Atlas Lung Adenocarcinoma 22 0.75 2.4
The Cancer Genome Atlas Lung Squamous Cell Carcinoma 28 1.12 2.5
The Cancer Genome Atlas Ovarian Serous Cystadenocarcinoma 13 0.82 2.3
The Cancer Genome Atlas Pancreatic Adenocarcinoma 16 0.96 2.6
The Cancer Genome Atlas Pheochromocytoma and Paraganglioma 6 0.45 2.2
The Cancer Genome Atlas Prostate Adenocarcinoma 39 0.84 2.2
The Cancer Genome Atlas Rectum Adenocarcinoma 7 1.01 2.3
The Cancer Genome Atlas Soft Tissue Sarcoma 4 0.37 2.1
The Cancer Genome Atlas Skin Cutaneous Melanoma 5 0.93 2.3
The Cancer Genome Atlas Stomach Adenocarcinoma 20 1.19 2.5
The Cancer Genome Atlas Testicular Germ Cell Tumors 18 1.41 2.6
The Cancer Genome Atlas Thyroid Carcinoma 42 0.81 2.4
The Cancer Genome Atlas Uterine Corpus Endometrial Carcinoma 5 0.98 2.6